[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BiopharmIQ by Amp [@BiopharmIQ](/creator/twitter/BiopharmIQ) on x 25.5K followers Created: 2025-01-28 17:35:57 UTC 🔔 Biotech Stock News 01/28 @ Open 🧬 📰 $NRXP XX% Funding Transaction for HOPE Clinic Acquisition $NBIX X% Ph3 Trial Initiation of Osavampator for Major Depression $ALLO X% IND Clearance for ALLO-329 $ACTI X% Patent for laquinimod in Eye Disorders $DRRX X% Publication of Larsucosterol Ph2b Study $HUMA X% Gene Editing Partnership with Pluristyx $AKRO X% Proposed Public Offering $ETNB X% Proposed Underwritten Public Offering $GOSS -X% Clinical & Preclinical Data at PVRI $AZN -X% US Approval for Breast Cancer Treatment $EPIX -X% Pricing of $5M Public Offering $LCTX -X% Second Tranche Closing of Direct Offering $INTS -X% Ph3 INVINCIBLE-3 Study Continuation $RHHBY -X% Itovebi Survival Benefit in HR-positive Breast Cancer $APLS -X% Approval of Pegcetacoplan in Australia $INMB -X% Expands INKmune Trial in Prostate Cancer $GSK -X% EMA Submissions for Depemokimab $SONN -X% Expands Global IP Portfolio with EU Patent $LNTH -X% Acquires Evergreen Theragnostics for $250M $SXTP -X% Phase II Study for Chronic Babesiosis $PCSA -XX% Pricing of $5M Public Offering $EVAX -XX% Nasdaq grants 180-day compliance extension $LPTX -XX% Initial Clinical Data from DeFianCe and DisTinGuish Studies 💠Checkout @srqstockpicker 's thoughts on $LPTX crash following initial data from DeFianCe and DisTinGuish 📉  XXXXX engagements  **Related Topics** [$lptx](/topic/$lptx) [$etnb](/topic/$etnb) [primary market](/topic/primary-market) [$akro](/topic/$akro) [$drrx](/topic/$drrx) [$acti](/topic/$acti) [$allo](/topic/$allo) [$nbix](/topic/$nbix) [Post Link](https://x.com/BiopharmIQ/status/1884294356905115686)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BiopharmIQ by Amp @BiopharmIQ on x 25.5K followers
Created: 2025-01-28 17:35:57 UTC
🔔 Biotech Stock News 01/28 @ Open 🧬 📰
$NRXP XX% Funding Transaction for HOPE Clinic Acquisition $NBIX X% Ph3 Trial Initiation of Osavampator for Major Depression $ALLO X% IND Clearance for ALLO-329 $ACTI X% Patent for laquinimod in Eye Disorders
$DRRX X% Publication of Larsucosterol Ph2b Study $HUMA X% Gene Editing Partnership with Pluristyx $AKRO X% Proposed Public Offering $ETNB X% Proposed Underwritten Public Offering
$GOSS -X% Clinical & Preclinical Data at PVRI $AZN -X% US Approval for Breast Cancer Treatment $EPIX -X% Pricing of $5M Public Offering $LCTX -X% Second Tranche Closing of Direct Offering $INTS -X% Ph3 INVINCIBLE-3 Study Continuation $RHHBY -X% Itovebi Survival Benefit in HR-positive Breast Cancer $APLS -X% Approval of Pegcetacoplan in Australia $INMB -X% Expands INKmune Trial in Prostate Cancer $GSK -X% EMA Submissions for Depemokimab $SONN -X% Expands Global IP Portfolio with EU Patent $LNTH -X% Acquires Evergreen Theragnostics for $250M $SXTP -X% Phase II Study for Chronic Babesiosis $PCSA -XX% Pricing of $5M Public Offering $EVAX -XX% Nasdaq grants 180-day compliance extension $LPTX -XX% Initial Clinical Data from DeFianCe and DisTinGuish Studies
💠Checkout @srqstockpicker 's thoughts on $LPTX crash following initial data from DeFianCe and DisTinGuish 📉
XXXXX engagements
Related Topics $lptx $etnb primary market $akro $drrx $acti $allo $nbix